Literature DB >> 1622181

Resistance of Peptostreptococcus spp. to macrolides and lincosamides: inducible and constitutive phenotypes.

M Reig1, A Moreno, F Baquero.   

Abstract

The activities of erythromycin and clindamycin against 350 Peptostreptococcus strains were studied during a 5-year period (1986 to 1991). In 5.1% of the Peptostreptococcus strains, which presented dissociated resistance (clindamycin MIC, less than or equal to 1 microgram/ml; erythromycin MIC, greater than 8 micrograms/ml), evidence of inducible macrolide-lincosamide resistance was shown. A total of 17.7% of the strains presented a constitutive phenotype; the clindamycin and erythromycin MICs for these strains were greater than 8 micrograms/ml.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1622181      PMCID: PMC190575          DOI: 10.1128/AAC.36.3.662

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.

Authors:  H M Wexler; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

2.  Susceptibility of anaerobic bacteria to FCE 22101.

Authors:  C E Nord; A Lindmark; I Person
Journal:  Antimicrob Agents Chemother       Date:  1987-05       Impact factor: 5.191

3.  Selection of constitutively resistant mutants of inducible clindamycin-resistant Bacteroides vulgatus.

Authors:  M Reig; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

4.  The control region for erythromycin resistance: free energy changes related to induction and mutation to constitutive expression.

Authors:  S Horinouchi; B Weisblum
Journal:  Mol Gen Genet       Date:  1981

5.  Erythromycin-inducible resistance in Staphylococcus aureus: requirements for induction.

Authors:  B Weisblum; C Siddhikol; C J Lai; V Demohn
Journal:  J Bacteriol       Date:  1971-06       Impact factor: 3.490

6.  In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections.

Authors:  M J Ohm-Smith; R L Sweet
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

7.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

8.  Susceptibility of anaerobic bacteria from several French hospitals to three major antibiotics.

Authors:  L Dubreuil; J Devos; C Neut; C Romond
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

9.  Antimicrobial susceptibilities of anaerobic bacteria isolated from female genital tract infections.

Authors:  G B Hill; O M Ayers
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

10.  Occurrence of clindamycin-resistant anaerobic bacteria isolated from cultures taken following clindamycin therapy.

Authors:  M J Ohm-Smith; R L Sweet; W K Hadley
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

  10 in total
  4 in total

1.  Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes.

Authors:  M Reig; J Galan; F Baquero; J C Perez-Diaz
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

Review 2.  Gram-positive anaerobic cocci.

Authors:  D A Murdoch
Journal:  Clin Microbiol Rev       Date:  1998-01       Impact factor: 26.132

3.  Effect of CO2 on susceptibilities of anaerobes to erythromycin, azithromycin, clarithromycin, and roxithromycin.

Authors:  S K Spangler; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

Review 4.  Resistance of anaerobic bacteria to antimicrobial agents in Spain.

Authors:  F Baquero; M Reig
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.